Has Kashyap Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $380,360 in general payments to Kashyap Patel, MD across 1,011 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kashyap Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kashyap Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kashyap Patel, MD

Hematology & Oncology · Rock Hill, SCNPI 1578675104

Payments from drug & device makers

$380,360in general payments, 2019–2025

Across 1,011 payments — averaging $376.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$69K
Secura Bio, Inc.$49K
Sobi, Inc$40K
Pfizer$27K
Eli Lilly$21K
Amgen$20K
plus $152K from 54 others

$9,083in research payments, 2019–2025

Across 4 payments — averaging $2270.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$9K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	52	$69,151
Secura Bio, Inc.	32	$49,086
Sobi, Inc	34	$40,057
Pfizer	48	$26,628
Eli Lilly	3	$21,425
Amgen	35	$20,131
Coherus Oncology, Inc.	21	$15,652
E.r. Squibb & Sons, L.L.C.	47	$14,699
AstraZeneca(2 entities)	34	$14,071
GE HealthCare	4	$13,082
Sandoz	7	$12,889
Merck	27	$11,596
Johnson & Johnson(3 entities)	63	$9,390
GSK	14	$6,076
Genentech USA, Inc.	18	$4,922
AbbVie	32	$4,482
Partner Therapeutics, Inc.	4	$4,440
Illumina, Inc.	8	$3,558
Oxford GENE Technology Inc	2	$2,958
Dova Pharmaceuticals	3	$2,535
Fresenius Kabi USA, LLC	8	$2,494
Janssen Global Services, LLC	2	$2,335
CTI Biopharma Corp.	13	$2,122
Taiho Oncology, Inc.	41	$2,119
Advanced Accelerator Applications	2	$1,891
Seagen Inc.	9	$1,739
Daiichi Sankyo Inc.	29	$1,676
ASD Specialty Healthcare, LLC	19	$1,574
Novartis	63	$1,475
Pharmacosmos Therapeutics Inc.	25	$1,434
Bristol Myers Squibb	16	$969
Eisai Inc.	23	$919
Athenex Pharmaceutical Division, LLC	2	$867
Beigene USA, Inc.	3	$728
Astrazeneca UK Limited	1	$685
Foundation Medicine, Inc.	8	$565
Sun Pharmaceutical Industries Inc.	11	$553
Takeda Pharmaceuticals U.S.A., Inc.	12	$525
Janssen Scientific Affairs, LLC	7	$492
Intrinsiq Specialty Solutions, Inc.	10	$482
Cardinal Health 110 LLC	2	$465
Gilead(2 entities)	23	$449
Astellas Pharma US Inc	6	$402
Roche Diagnostics Corporation	8	$390
Lilly USA, LLC	17	$381
Fennec Pharmaceuticals, Inc.	2	$380
Adaptive Biotechnologies Corporation	9	$329
Regeneron Healthcare Solutions, Inc.	9	$316
Genentech, Inc.	3	$281
Spectrum Pharmaceuticals Inc.	5	$266
Exelixis Inc.	13	$262
Boehringer Ingelheim	12	$249
Karyopharm Therapeutics Inc.	8	$227
Ipsen Biopharmaceuticals, Inc	5	$217
Morphosys, US Inc.	4	$214
Organon	2	$212
Celltrion USA Inc.	4	$211
Bayer	4	$201
Stemline Therapeutics Inc.	2	$197
Incyte Corporation	8	$171

How this compares

$380,360 in reported general payments places this provider in the 85th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$866,104

Medicare patients

121

Services billed

32,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Rock Hill

Sashi NaiduRock Hill$834K
Viral RabaraRock Hill$138K
Asutosh GorRock Hill$40K
Ki ChungSpartanburg$4.7M
Stephen DyarGreenville$4.5M
Suzanne FanningGreenville$3.9M
Vikas DemblaSpartanburg$3.2M
Robert StuartCharleston$2.9M
Tondre BuckSpartanburg$2.1M
William EdenfieldGreenville$1.7M

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →